arrow
M

Mark C. Walters

university of california–san francisco
H指数:48
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reduced-Intensity Haploidentical Bone Marrow Transplantation in Children with Severe Sickle Cell Disease: BMT CTN 1507

低强度半相合骨髓移植在重症镰状细胞病儿童中的应用:BMT CTN 1507

2026-01-010
OAAI
Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDT

非临床评估renizgamglogene autogedtemcel在SCD和TDT中的应用

2025-09-230
PREAI
Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Successful Engraftment, Increased Hemoglobin, and Reduced Transfusion Dependence in Patients with Transfusion-Dependent Beta-Thalassemia Treated in the Edithal Trial

Reni-Cel,一种正在研究的AsCas12a基因编辑细胞药物,在Edithal试验中治疗依赖输血的β-地中海贫血患者时,实现了成功植入、增加了血红蛋白含量并降低了输血依赖性。

BLOOD
IF23.1
2024-11-050
PRE
An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel

关于Lovotibeglogene Autotemcel(Lovo-cel)治疗镰状细胞病(SCD)的临床试验进展及对Lovo-cel反应的早期预测因子分析

BLOOD
IF23.1
2024-11-050
PRE
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial

Betibeglogene autotemcel基因治疗输血依赖性,严重基因型 β-地中海贫血 (HGB-212) 患者: 一项非随机,多中心,单臂,开放标签,单剂量,3期试验

LANCET
IF88.5
2024-11-010
PRE
Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease
2024-10-160
OAAI
Exagamglogene Autotemcel for Severe Sickle Cell Disease
2024-05-0954
PRE
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial

BMT CTN 0601试验中严重镰状细胞病的无关供体移植后的长期结果

2024-02-111
PRE
Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients

在代表性不足的人群中获得嵌合抗原受体T细胞临床试验: 儿童和年轻成人急性淋巴细胞白血病患者的多中心队列研究

2023-06-0114
OAAI
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials

异基因造血干细胞移植与omiudubicel的多中心长期随访: 五项前瞻性临床试验的汇总分析

2023-05-017
OAAI
Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia

Betibeglogene Autotemcel基因治疗非 β0/β0基因型 β 地中海贫血

2022-02-03123
OA
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year
2021-11-0113
OAAI